AIDS-related progressive multifocal leukoencephalopathy (PML): a retrospective study from Pretoria, South Africa

C-M Schutte1, N Ranchhod, M Kakaza

  • 1Department of Neurology, University of Pretoria, Pretoria, South Africa. cschutte@medic.up.ac.za

Abstract

Insights

Progressive multifocal leukoencephalopathy (PML) is increasingly diagnosed in South African HIV patients. This study details the clinical and radiological features of PML in this population.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Virology

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a rare, opportunistic demyelinating disease caused by the John Cunningham (JC) virus.
  • PML incidence increased significantly after the HIV pandemic, yet reports from Africa remain scarce.
  • Recent observations indicated a rise in PML cases at a South African tertiary hospital.

Purpose of the Study:

  • To describe the clinical and radiological characteristics of PML in South African patients.
  • To highlight the occurrence of PML in the context of HIV infection in South Africa.

Main Methods:

  • Retrospective identification of adult patients with confirmed JC virus in cerebrospinal fluid (CSF) via real-time PCR (January 2008 - June 2012).
  • Analysis of clinical manifestations, laboratory findings (including CD4 counts), and neuroimaging (CT and MRI) data.
  • Review of 17 available patient records.

Main Results:

  • JC virus was detected in 19 of 121 specimens; 17 patients' data were analyzed (ages 27-64).
  • Common clinical symptoms included focal weakness (47%), impaired coordination (41%), and speech disturbances (12%).
  • CSF analysis revealed high protein (76%) and pleocytosis (35%). Neuroimaging showed white matter lesions consistent with PML.

Conclusions:

  • This is the first case series of PML from a South African neurology unit.
  • The findings emphasize that PML is a common occurrence in South African patients with HIV infection.
  • PML should be considered in the differential diagnosis of neurological disorders in HIV-positive individuals in this region.